Biomarin Pharmaceutical Stock Performance Review
Biomarin Pharmaceutical’s stock price as of the latest market data is $56.22 USD.
Recent Price Movement The current stock price represents a decline from the 52-week high of $94.85 USD, achieved on August 19th, 2024.
Price Stability Conversely, the stock has maintained a relatively stable low of $52.93 USD since April 8th, this year.
Valuation Metrics The company’s price-to-earnings ratio is 21.26, and the price-to-book ratio is 1.9, providing a technical analysis of the asset’s valuation.
Key Statistics
- 52-week high: $94.85 USD (August 19th, 2024)
- Current stock price: $56.22 USD
- 52-week low: $52.93 USD (April 8th, this year)
- Price-to-earnings ratio: 21.26
- Price-to-book ratio: 1.9